|
|
||||||||
Receptors1






Departments of
*
Microbiology/Immunology and
Anatomy, Division of Immunobiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298;
Department of Microbiology, Brigham Young University, Provo, UT 84602; and
Department of Neurology, Johns Hopkins University, Baltimore, MD 21287
Large quantities of HIV are found trapped on the surface of
follicular dendritic cells (FDCs), and virus persists on these cells
until they ultimately die. We recently found that FDCs maintain HIV
infectivity for long periods in vivo and in vitro. Because FDCs trap
Ags (and virus) in the form of immune complexes and are rich in
Fc
Rs, we reasoned that Ab and Fc
Rs may be required for
FDC-mediated maintenance of HIV infectivity. To investigate this
hypothesis, HIV immune complexes were formed in vitro and incubated for
increasing times with or without FDCs, after which the remaining
infectious virus was determined by HIV-p24 production in rescue
cultures. FDCs maintained HIV infectivity in vitro in a dose-dependent
manner but required the presence of specific Ab for this activity
regardless of whether laboratory-adapted or primary X4 and R5 isolates
were tested. In addition, Abs against either virally or host-encoded
proteins on the virion permitted FDC-mediated maintenance of HIV
infectivity. We found that the addition of FDCs to HIV immune complexes
at the onset of culture gave optimal maintenance of infectivity.
Moreover, blocking FDC-Fc
Rs or killing the FDCs dramatically reduced
their ability to preserve virus infectivity. Finally, FDCs appeared to
decrease the spontaneous release of HIV-1 gp120, suggesting that
FDC-virus interactions stabilize the virus particle, thus contributing
to the maintenance of infectivity. Therefore, optimal maintenance of
HIV infectivity requires both Ab against particle-associated
determinants and FDC-Fc
Rs.
This article has been cited by other articles:
![]() |
B. F. Keele, L. Tazi, S. Gartner, Y. Liu, T. B. Burgon, J. D. Estes, T. C. Thacker, K. A. Crandall, J. C. McArthur, and G. F. Burton Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1 J. Virol., June 1, 2008; 82(11): 5548 - 5561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wilflingseder, Z. Banki, E. Garcia, M. Pruenster, G. Pfister, B. Muellauer, D. S. Nikolic, C. Gassner, C. G. Ammann, M. P. Dierich, et al. IgG Opsonization of HIV Impedes Provirus Formation in and Infection of Dendritic Cells and Subsequent Long-Term Transfer to T Cells J. Immunol., June 15, 2007; 178(12): 7840 - 7848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ho, S. Moir, L. Kulik, A. Malaspina, E. T. Donoghue, N. J. Miller, W. Wang, T.-W. Chun, A. S. Fauci, and V. M. Holers Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues J. Immunol., June 1, 2007; 178(11): 6968 - 6974. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Moore, E. T. Crooks, L. Porter, P. Zhu, C. S. Cayanan, H. Grise, P. Corcoran, M. B. Zwick, M. Franti, L. Morris, et al. Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1 J. Virol., March 1, 2006; 80(5): 2515 - 2528. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Holl, S. Hemmerter, R. Burrer, S. Schmidt, A. Bohbot, A.-M. Aubertin, and C. Moog Involvement of Fc{gamma}R I (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified from Infected Patients in Cultured Monocyte-Derived Macrophages J. Immunol., November 15, 2004; 173(10): 6274 - 6283. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Poignard, M. Moulard, E. Golez, V. Vivona, M. Franti, S. Venturini, M. Wang, P. W. H. I. Parren, and D. R. Burton Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies J. Virol., December 6, 2002; 77(1): 353 - 365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |